The GLP is committed to full transparency. Download and review our just-released 2019 Annual Report.

October glyphosate-cancer trial delayed as settlement negotiations continue, Bayer says

| | October 7, 2019

A pending U.S. lawsuit over claims related to Bayer’s (BAYGn.DE) glyphosate-based herbicide Roundup has been delayed, the company said on [October 6], with a new court date set for February, 2020.

“The Oct. 15, 2019 trial date for Winston v. Monsanto in St. Louis City has been postponed,” Bayer said in a statement.

The lawsuit is the latest of several to be delayed as mediator Ken Feinberg tries to negotiate a settlement between the company and U.S. plaintiffs after a California jury in August last year found that Monsanto should have warned of alleged cancer risks.

Read full, original article: Bayer says October U.S. glyphosate trial delayed until February

Related article:  Anti-GMO Activism and Its Impact on Food Security
The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend